Nature Publishing Group, publisher of Nature, and other science journals and reference works NATURE.COM NATURE NEWS NATUREJOBS NATUREEVENTS ABOUT NPG
Help Nature.com site index  
Leukemia
SEARCH     advanced search my account e-alerts subscribe register
Journal home
Advance online publication
Current issue
Archive
Press releases
For authors
For referees
Contact editorial office
About the journal
For librarians
Subscribe
Advertising
naturereprints
Contact NPG
Customer services
Site features
NPG Subject areas
Access material from all our publications in your subject area:
Biotechnology Biotechnology
Cancer Cancer
Chemistry Chemistry
Dentistry Dentistry
Development Development
Drug Discovery Drug Discovery
Earth Sciences Earth Sciences
Evolution & Ecology Evolution & Ecology
Genetics Genetics
Immunology Immunology
Materials Materials Science
Medical Research Medical Research
Microbiology Microbiology
Molecular Cell Biology Molecular Cell Biology
Neuroscience Neuroscience
Pharmacology Pharmacology
Physics Physics
Browse all publications
 


April 2001, Volume 15, Number 4

Table of Contents

<Previous    Issue    Next >
Reviews
Phosphorylation of Bcl2 and regulation of apoptosis FREE
P P Ruvolo, X Deng & W S May
Abstract  |  Full text  |  PDF 515
Gene therapy: principles and applications to hematopoietic cells FREE
V F I Van Tendeloo, C Van Broeckhoven & Z N Berneman
Abstract  |  Full text  |  PDF 523
Gene-based cancer vaccines: an ex vivo approach FREE
V F I Van Tendeloo, C Van Broeckhoven & Z N Berneman
Abstract  |  Full text  |  PDF 545
Original Manuscripts
Cell cycle regulatory protein expression in fresh acute myeloid leukemia cells and after drug exposure FREE
N Radosevic, A Delmer, R Tang, J-P Marie & F Ajchenbaum-Cymbalista
Abstract  |  Full text  |  PDF 559
Apoptotic response to homoharringtonine in human wt p53 leukemic cells is independent of reactive oxygen species generation and implicates Bax translocation, mitochondrial cytochrome c release and caspase activation FREE
Z Cai, M Lin, C Wuchter, V Ruppert, B Dörken, W-D Ludwig & L Karawajew
Abstract  |  Full text  |  PDF 567
ABL1 methylation in Ph-positive ALL is exclusively associated with the P210 form of BCR-ABL FREE
P J Shteper, Z Siegfried, F A Asimakopoulos, G A Palumbo, E A Rachmilewitz, Y Ben-Neriah & D Ben-Yehuda
Abstract  |  Full text  |  PDF 575
The diagnostic significance of Myf-3 hypermethylation in malignant lymphoproliferative disorders FREE
J M E Taylor, P H Kay & D V Spagnolo
Abstract  |  Full text  |  PDF 583
Effect of a selective Abl tyrosine kinase inhibitor, STI571, on in vitro growth of BCR-ABL-positive acute lymphoblastic leukemia cells FREE
Y Kawaguchi, I Jinnai, K Nagai, F Yagasaki, Y Yakata, T Matsuo, K Kuriyama & M Tomonaga
Abstract  |  Full text  |  PDF 590
Cryptic t(4;11) encoding MLL-AF4 due to insertion of 5' MLL sequences in chromosome 4 FREE
A von Bergh, P Gargallo, B De Prijck, H Vranckx, R Marschalek, I Larripa, Ph Kluin, E Schuuring & A Hagemeijer
Abstract  |  Full text  |  PDF 595
Cloning and expression of human HBP1, a high mobility group protein that enhances myeloperoxidase (MPO) promoter activity FREE
K M Lin, W-G Zhao, J Bhatnagar, W-D Zhao, J-P Lu, S Simko, A Schueneman & G E Austin
Abstract  |  Full text  |  PDF 601
Potentiatied antitumor effectiveness of combined chemo-immunotherapy with Interleukin-12 and 5-fluorouracil of L1210 leukemia in vivo FREE
J Gol strokeacedilb, R Zagozdotdzdoton, R Kamin acuteski, K Kozar, K Gryska, D Izdotycki, A Mackiewicz, T Stokl strokeosa, A Giermasz, W Lasek & M Jakóbisiak
Abstract  |  Full text  |  PDF 613
Somatostatin induces migration of acute myeloid leukemia cells via activation of somatostatin receptor subtype 2 FREE
S P M A Oomen, E G R Lichtenauer-Kaligis, N Verplanke, J Hofland, S W J Lamberts, B Löwenberg & I P Touw
Abstract  |  Full text  |  PDF 621
Molecular heterogeneity of splenic marginal zone lymphomas: analysis of mutations in the 5' non-coding region of the bcl-6 gene FREE
M-S Mateo, M Mollejo, R Villuendas, P Algara, M Sanchez-Beato, P Martínez & M A Piris
Abstract  |  Full text  |  PDF 628
Long-term clinical and molecular remission after allogeneic stem cell transplantation (SCT) in patients with poor prognosis non-Hodgkin's lymphoma FREE
M Mitterbauer, P Neumeister, P Kalhs, S Brugger, G Fischer, K Dieckmann, P Hoecker, W Hinterberger, W Linkesch, I Simonitsch, U Jaeger, K Lechner, C Mannhalter, G Mitterbauer & H T Greinix
Abstract  |  Full text  |  PDF 635
Immunotherapy by non-myeloablative allogeneic stem cell transplantation in multiple myeloma: results of a pilot study as salvage therapy after autologous transplantation FREE
F Garban, M Attal, J F Rossi, C Payen, N Fegueux & J J Sotto on behalf of the Intergroupe Francophone du Myelome
Abstract  |  Full text  |  PDF 642
Meeting Report
HTLV Molecular Biology and Pathogenesis: Airlie Center, Warrenton, VA, USA, 17-19 March 2000 FREE
Z N Berneman
Abstract  |  Full text  |  PDF 647
Acute Leukemia Forum 2000
Introduction FREE
Jacob M Rowe
Abstract  |  Full text  |  PDF 655
Introduction of Ernest Beutler, MD FREE
M A Lichtman
Abstract  |  Full text  |  PDF 656
The treatment of acute leukemia: past, present, and future FREE
E Beutler
Abstract  |  Full text  |  PDF 658
Nonmyeloablative preparative regimens: how relevant for acute myelogenous leukemia? FREE
R Storb
Abstract  |  Full text  |  PDF 662
AML1/CBFbold beta transcription complex: its role in normal hematopoiesis and leukemia FREE
J R Downing
Abstract  |  Full text  |  PDF 664
MDR modulation in acute myelogenous leukemia: is it dead? FREE
J E Karp
Abstract  |  Full text  |  PDF 666
Potential for therapy with AML-derived dendritic cells FREE
D Claxton & A Choudhury
Abstract  |  Full text  |  PDF 668
Prognostic factors in acute myelogenous leukemia FREE
E H Estey
Abstract  |  Full text  |  PDF 670
Small molecule mimics of hematopoietic growth factors: improving on Mother Nature? FREE
K Kaushansky
Abstract  |  Full text  |  PDF 673
New agents for induction and postremission therapy of acute myeloid leukemia FREE
R A Larson
Abstract  |  Full text  |  PDF 675
Uncertainties in the standard care of acute myelogenous leukemia FREE
J M Rowe
Abstract  |  Full text  |  PDF 677
Who should be transplanted for AML? FREE
F R Appelbaum
Abstract  |  Full text  |  PDF 680
Management of patients refractory to platelet transfusion FREE
C A Schiffer
Abstract  |  Full text  |  PDF 683
Marrow vs peripheral blood: impact on transplant outcome FREE
S J Forman
Abstract  |  Full text  |  PDF 686
Abnormalities of the CEBP alpha transcription factor: a major target in acute myeloid leukemia FREE
D G Tenen
Abstract  |  Full text  |  PDF 688
Targeted AML therapy: new biologic paradigms and therapeutic opportunities FREE
C L Willman
Abstract  |  Full text  |  PDF 690
Correspondence
Simultaneous occurrence of bcr-abl and inv16 in a case of M1 acute myeloid leukemia FREE
M Svaldi, A Lanthaler, R Venturi, P Coser & M Mitterer
Abstract  |  Full text  |  PDF 695
Synergistic effects of verapamil and anti-mdr1 ribozyme on reversion of multidrug resistance in the P-glycoprotein-positive K562 cell line FREE
Y Gong, W Han, J Liu, F Chen, J Han, Y Jin & R Ou Yong
Abstract  |  Full text  |  PDF 696
Cytarabine-induced aseptic meningitis FREE
H van den Berg, M van der Flier & Md van de Wetering
Abstract  |  Full text  |  PDF 697
April 2001, Volume 15, Number 4
<Previous    Issue    Next >
Privacy Policy © 2001 Nature Publishing Group